Top

Published in:

01-07-2013 | Work in Progress

Radioembolisation for treatment of pediatric hepatocellular carcinoma

Authors: Clifford Matthew Hawkins, Kamlesh Kukreja, James I. Geller, Carmen Schatzman, Ross Ristagno

Published in: Pediatric Radiology | Issue 7/2013

Abstract

Transarterial radioembolisation with yttrium-90 (TARE-Y90), a catheter-directed therapy, has been used extensively in adults to treat primary and secondary hepatic malignancies. To our knowledge, the use of this palliative technique has not been described in children. We present two children with unresectable hepatocellular carcinoma (HCC) treated with TARE-Y90.

Donnelly L (2009) Pediatric imaging: the fundamentals. Saunders Elsevier, Philadelphia

Gupta AA, Gerstle JT, Ng V et al (2011) Critical review of controversial issues in the management of advanced pediatric liver tumors. Pediatr Blood Cancer 56:1013–1018PubMedCrossRef

Katzenstein HM, Krailo MD, Malogolowkin MH et al (2002) Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children’s Cancer Group intergroup study. J Clin Oncol 20:2789–2797PubMedCrossRef

Kennedy AS, McNeillie P, Dezarn WA et al (2009) Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 74:1494–1500PubMedCrossRef

National Cancer Institute Childhood Liver Cancer Treatment (PDQ®) (2012) http://www.cancer.gov/cancertopics/pdq/treatment/childliver/HealthProfessional/. Accessed 26 October 2012

Lewandowski RJ, Geschwind JF, Liapi E et al (2011) Transcatheter intraarterial therapies: rationale and overview. Radiology 259:641–657PubMedCrossRef

D’Avola D, Lnarrairaegui M, Bilbao JI et al (2009) A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma. Hepatogastroenterology 56:1683–1688PubMed

Lewandowski RJ, Kulik LM, Riaz A et al (2009) A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 9:1920–1928PubMedCrossRef

Salem R, Lewandowski RJ, Mulcahy MF et al (2010) Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 138:52–64PubMedCrossRef

10.

Czauderna P, Mackinlay G, Perilongo G et al (2002) Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 20:2798–2804PubMedCrossRef

11.

Salem R, Lewandowski RJ, Atassi B et al (2005) Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16:1627–1639PubMedCrossRef

12.

Goin JE, Salem R, Carr BI et al (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:205–213PubMedCrossRef

13.

Yang CW, Yen HH, Su WW et al (2010) Profound transient thrombocytopenia associated with 90Yttrium microsphere therapy for inoperable hepatoma. South Med J 103:1264–1268PubMedCrossRef

14.

Salem R, Lewandowski RJ, Kulik L et al (2011) Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 140:497–507PubMedCrossRef

15.

Carr BI, Kondragunta V, Buch SC et al (2010) Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study. Cancer 116:1305–1314PubMedCrossRef

16.

Kooby DA, Egnatashvili V, Srinivasan S et al (2010) Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 21:224–230PubMedCrossRef

17.

Salem R, Lewandowski RJ, Gates VL et al (2011) Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol 22:265–278PubMedCrossRef

Title: Radioembolisation for treatment of pediatric hepatocellular carcinoma
Authors: Clifford Matthew Hawkins
Kamlesh Kukreja
James I. Geller
Carmen Schatzman
Ross Ristagno
Publication date: 01-07-2013
Publisher: Springer-Verlag
Published in: Pediatric Radiology / Issue 7/2013
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI: https://doi.org/10.1007/s00247-012-2568-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Radioembolisation for treatment of pediatric hepatocellular carcinoma

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2013

Role of plain radiography and CT angiography in the evaluation of obstructed total anomalous pulmonary venous connection

Neuroimaging in childhood headache: a systematic review

Reply to Findley et al. regarding Daubert and the rules of evidence

Interactive digital atlas of skeletal surveys for common skeletal dysplasias

Radiofrequency ablation in the treatment of osteoid osteoma: results and complications

MRI assessment of tenosynovitis in children with juvenile idiopathic arthritis: inter- and intra-observer variability